Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
10/22/1996 | US5567817 Triazole antifungal agents |
10/22/1996 | US5567813 Acylation in presence of a solvent and a base |
10/22/1996 | US5567738 Use of 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-Naphthoquinone for the treatment of cancer |
10/22/1996 | US5567719 Thiadiazoles and their use as antipicornaviral agents |
10/22/1996 | US5567716 Trans and cis traumatic acid salts having cicatrizant activity associated to bacteriostatic, antiviral, antibiotic or antifungal activity |
10/22/1996 | US5567698 Bacterisides |
10/22/1996 | US5567692 9-[(substituted glycyl) amido)]-6-demethyl-6-deoxytetracyclines |
10/22/1996 | US5567689 Methods for increasing uridine levels with L-nucleosides |
10/22/1996 | US5567688 L-nucleosides for the treatment of hepatitis B-virus |
10/22/1996 | US5567681 PGLa and XPF peptides and uses therefor |
10/22/1996 | US5567676 Bactericides |
10/22/1996 | US5567604 Anti-viral guanosine-rich oligonucleotides |
10/22/1996 | US5567594 Methods and compositions for the detection and treatment of diseases associated with antigens of microorganisms |
10/22/1996 | US5567582 Dna sequences |
10/22/1996 | CA2174473A1 Heteroatom-containing benzocyclopentane oxazolidinones |
10/22/1996 | CA1338670C .beta.-lactam antibiotics |
10/17/1996 | WO1996032482A1 Bacteriocins |
10/17/1996 | WO1996032416A1 Novel anti-aids immunotoxins |
10/17/1996 | WO1996032401A1 Quillaja saponin adjuvant and vaccine formulation containing same |
10/17/1996 | WO1996032376A1 Novel borneol esters, process for their preparation and their pharmaceutical use |
10/17/1996 | WO1996032160A1 Mask for treating cold |
10/17/1996 | WO1996032128A1 Isolated 55 to 75 kda protein which binds to prion protein |
10/17/1996 | WO1996032122A1 Mistletoe extract and method |
10/17/1996 | WO1996032111A1 Trapidil for use in the treatment of immuno-modulatorily influencible cases |
10/17/1996 | WO1996032107A1 A pharmaceutical composition containing benzimidazole for inhibiting the growth of cancers |
10/17/1996 | WO1996032104A1 A pharmaceutical composition containing n-chlorophenylcarbamates and n-chlorophenylthiocarbamates for inhibiting the growth of viruses and cancers |
10/17/1996 | WO1996032103A1 A pharmaceutical composition containing n-chlorophenylcarbamates, n-chlorophenylthiocarbamates and n-phosphonoglycine derivatives for inhibiting the growth of cancers and viruses in mammals |
10/17/1996 | WO1996021020A3 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases |
10/17/1996 | WO1996017951A3 Identification of genes responsible for in vivo survival of microorganisms |
10/17/1996 | WO1996016173A3 Modified proteinase inhibitors |
10/17/1996 | DE19514048A1 Trapidil zur Verwendung in der Therapie von immunmodulatorisch beeinflußbaren Krankheitsbildern Trapidil for use in the treatment of immunomodulatory influenced diseases |
10/17/1996 | CA2246629A1 Mask for treating cold |
10/17/1996 | CA2217955A1 A pharmaceutical composition containing n-chlorophenylcarbamates, n-chlorophenylthiocarbamates and n-phosphonoglycine derivatives for inhibiting the growth of cancers and viruses in mammals |
10/17/1996 | CA2217947A1 Isolated 55 to 75 kda protein which binds to prion protein |
10/17/1996 | CA2216655A1 New borneol esters, process for their production, and their pharmaceutical use |
10/17/1996 | CA2216210A1 Novel anti-aids immunotoxins |
10/16/1996 | EP0737750A2 Expression of exogenous polynucleotide sequences in a vertebrate |
10/16/1996 | EP0737248A1 Gene expression control |
10/16/1996 | EP0737247A1 Method and reagent for inhibiting hepatitis c virus replication |
10/16/1996 | EP0737205A1 T-cell epitopes |
10/16/1996 | EP0737085A1 VACCINE FOR $i(BRANHAMELLA CATARRHALIS) |
10/16/1996 | EP0737072A1 A method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans |
10/16/1996 | EP0663833B1 Royal jelly |
10/16/1996 | EP0639176B1 Benzenedimethanol suitable for micronisation |
10/16/1996 | EP0610179B1 Target specific antibody-superantigen conjugates and their preparation |
10/16/1996 | EP0601062B1 Sirs vaccine and diagnosis method |
10/16/1996 | EP0429477B1 Synthetic vaccine against aids virus |
10/16/1996 | CN1133594A Hsv-2 UL26 gene, capsid proteins, immunoassays and protease inhibitors |
10/16/1996 | CN1133294A Closed-large ring lactone and closed-azalactone group new compounds and preparation process thereof |
10/16/1996 | CN1133291A Erythromycin derivant and preparation method and usage of medicine thereof |
10/16/1996 | CN1133287A Inhibitor for squalene synthetic enzyme |
10/16/1996 | CN1033043C Process for preparation of glucuromide glycoside antibiotic A40926 |
10/16/1996 | CN1033003C Method of preparing toxid |
10/15/1996 | US5565571 Substituted aryl- and heteroaryl-phenyloxazolidinones |
10/15/1996 | US5565565 One step akylation and concurrently generating the akylation catalyst |
10/15/1996 | US5565560 Treating autoimmune diseases, preventing transplant rejection |
10/15/1996 | US5565559 Culturing an fr-900506; protecting; salt formation; oxidation; reduction; deprotecting |
10/15/1996 | US5565549 Retroviruse, aids |
10/15/1996 | US5565448 Antiinflammatory agent, cardiovascular disorders, septic shock |
10/15/1996 | US5565446 Useful in treatment of inflammatory diseases |
10/15/1996 | US5565438 L-nucleosides for the treatment of epstein-bar virus |
10/15/1996 | US5565425 Viral infection and proliferation inhibitors |
10/15/1996 | US5565205 Immunizing a swine against infection |
10/15/1996 | US5565203 Hepatitis A virus in a reconstituted influenza virosome and use as a vaccine |
10/15/1996 | CA1338644C Production of 3-allyl- and 3-butenyl-3-cephems |
10/10/1996 | WO1996031618A1 ISOLATED FrpB NUCLEIC ACID MOLECULE AND VACCINE |
10/10/1996 | WO1996031607A2 Use of an 'immunodeficiency-virus suppressing lymphokine (isl)' to inhibit the replication of viruses, in particular of retroviruses |
10/10/1996 | WO1996031537A1 Agents for binding to advanced glycosylation endproducts, and methods of their use |
10/10/1996 | WO1996031527A1 Protease inhibiting succinic acid derivatives |
10/10/1996 | WO1996031511A1 5H,10H-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-4-ONE DERIVATIVES, PREPARATION THEREOF, AND DRUGS CONTAINING SAID DERIVATIVES |
10/10/1996 | WO1996031490A1 Azole compounds with antimycotic activity for human and veterinary use |
10/10/1996 | WO1996031235A1 Composition for inducing a mucosal immune response |
10/10/1996 | WO1996031228A1 Cyclic peptide antifungal agents |
10/10/1996 | WO1996031186A2 Product and method for preventing respiratory virus infection |
10/10/1996 | WO1996021465A3 Immunogenic conjugate molecules |
10/10/1996 | WO1996020215A3 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases |
10/10/1996 | CA2217695A1 Azole compounds with antimycotic activity for human and veterinary use |
10/10/1996 | CA2217572A1 Agents for binding to advanced glycosylation endproducts, and methods of their use |
10/10/1996 | CA2217450A1 Use of an "immunodeficiency-virus suppressing lymphokine (isl)" to inhibit the replication of viruses, in particular of retroviruses |
10/10/1996 | CA2217048A1 Cyclic peptide antifungal agents |
10/10/1996 | CA2215469A1 5h,10h-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one derivatives, preparation thereof, and drugs containing said derivatives |
10/10/1996 | CA2212562A1 Product and method for preventing respiratory virus infection |
10/10/1996 | CA2192473A1 Composition for inducing a mucosal immune response |
10/09/1996 | EP0736541A1 Cyclic hexapeptide antifungal agents |
10/09/1996 | EP0736522A1 Ceramide compounds, process for their preparation and their use in cosmetics or dermatology |
10/09/1996 | EP0736299A1 Process for preparing a liposomal, water-dispersable, solid, dry, therapeutic formulation for oral administration |
10/09/1996 | EP0736180A1 Methods and compositions for the detection and treatment of diseases associated with antigens of microorganisms |
10/09/1996 | EP0736098A1 Mycobacteria virulence factors and a method for their identification |
10/09/1996 | EP0736089A1 Thermostable varicella zoster virus |
10/09/1996 | EP0736039A1 Compounds with growth hormone releasing properties |
10/09/1996 | EP0736030A1 Tetrahydrofuran antifungals |
10/09/1996 | EP0736015A1 Novel antiviral 2,4-pyrimidinedione derivatives and processes for the preparation thereof |
10/09/1996 | EP0736013A1 N-substituted aryl trifluoromethyl imidazoles |
10/09/1996 | EP0735891A1 A 46 Kd HUMAN MILK FAT GLOBULE ANTIGEN |
10/09/1996 | EP0735878A1 Pharmaceuticals |
10/09/1996 | EP0735871A1 Pharmaceutical compositions containing ceftriaxone and penems |
10/09/1996 | EP0735818A1 MACROPHAGE INFLAMMATORY PROTEINS-3, -4 AND -1 Sg(g) |
10/09/1996 | EP0640088B1 Novel tricyclic thiazolo and thiazino derivatives and anti-viral medicaments containing them |
10/09/1996 | CN1133048A Oligopeptides derived from C-reactive protein fragments |
10/09/1996 | CN1133047A Therapeutic peptide derivatives |